Search

everythinglearnresearchcommunity

for

Search:↓

Prostate cancer was a major health issue in 2009, especially for Black men, and targeting the 5alpha-reductase enzyme could help in its prevention and treatment.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

Finasteride may help prevent prostate cancer.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

Dutasteride showed some prevention of prostate issues but also had limitations, especially with high-grade tumors.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

Finasteride therapy reduces PSA levels and prostate size, helping diagnose prostate cancer.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

ERG increases SOX9, promoting prostate cancer growth and invasion.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Higher cholesterol levels increase aggressive prostate cancer risk.

Monascus helps prevent baldness, prostate issues, and may be a natural alternative to medications.

Higher DHT in male baldness may protect against prostate cancer.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Suppressing certain hormones might help prevent prostate cancer.

Finasteride can reduce prostate cancer risk but may delay diagnosis and cause sexual side effects.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Pterostilbene significantly reduces prostate enlargement and has strong antioxidant effects.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Dutasteride may help shrink prostate cancer tumors.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.